STIM Neuronetics Inc

Price (delayed)

$1.89

Market cap

$56.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.95

Enterprise value

$71.44M

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial ...

Highlights
STIM's EPS is up by 30% YoY and by 10% from the previous quarter
The net income has grown by 25% YoY and by 9% from the previous quarter
Neuronetics's quick ratio has increased by 19% from the previous quarter but it has decreased by 2.3% YoY
The company's debt has surged by 55% YoY
STIM's equity is down by 43% year-on-year and by 19% since the previous quarter

Key stats

What are the main financial stats of STIM
Market
Shares outstanding
30M
Market cap
$56.7M
Enterprise value
$71.44M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.03
Price to sales (P/S)
0.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
Earnings
Revenue
$73.23M
EBIT
-$21.54M
EBITDA
-$19.49M
Free cash flow
-$31.35M
Per share
EPS
-$0.95
Free cash flow per share
-$1.06
Book value per share
$0.93
Revenue per share
$2.48
TBVPS
$3.52
Balance sheet
Total assets
$103.81M
Total liabilities
$76.16M
Debt
$62.47M
Equity
$27.66M
Working capital
$67.37M
Liquidity
Debt to equity
2.26
Current ratio
5.65
Quick ratio
4.7
Net debt/EBITDA
-0.76
Margins
EBITDA margin
-26.6%
Gross margin
72.9%
Net margin
-37.6%
Operating margin
-37.6%
Efficiency
Return on assets
-26.7%
Return on equity
-75.8%
Return on invested capital
-23.6%
Return on capital employed
-24.1%
Return on sales
-29.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STIM stock price

How has the Neuronetics stock price performed over time
Intraday
-1.05%
1 week
-5.5%
1 month
3.28%
1 year
-8.25%
YTD
-34.83%
QTD
5%

Financial performance

How have Neuronetics's revenue and profit performed over time
Revenue
$73.23M
Gross profit
$53.4M
Operating income
-$27.51M
Net income
-$27.54M
Gross margin
72.9%
Net margin
-37.6%
The company's net margin rose by 32% YoY and by 11% QoQ
The company's operating margin rose by 28% YoY and by 12% QoQ
The net income has grown by 25% YoY and by 9% from the previous quarter
STIM's operating income is up by 21% YoY and by 10% from the previous quarter

Growth

What is Neuronetics's growth rate over time

Valuation

What is Neuronetics stock price valuation
P/E
N/A
P/B
2.03
P/S
0.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
STIM's EPS is up by 30% YoY and by 10% from the previous quarter
STIM's equity is down by 43% year-on-year and by 19% since the previous quarter
STIM's price to book (P/B) is 18% less than its 5-year quarterly average of 2.5 and 18% less than its last 4 quarters average of 2.5
The P/S is 67% below the 5-year quarterly average of 2.3 and 30% below the last 4 quarters average of 1.1
The revenue has grown by 10% YoY and by 2.6% from the previous quarter

Efficiency

How efficient is Neuronetics business performance
STIM's ROIC has soared by 53% YoY and by 21% from the previous quarter
STIM's ROS is up by 39% YoY and by 15% from the previous quarter
The ROE has contracted by 22% YoY and by 4.1% from the previous quarter
The return on assets has increased by 16% year-on-year and by 9% since the previous quarter

Dividends

What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STIM.

Financial health

How did Neuronetics financials performed over time
The total assets is 36% more than the total liabilities
The company's total liabilities rose by 38% YoY but it fell by 7% QoQ
STIM's current ratio is up by 19% from the previous quarter and by 5% YoY
The company's debt is 126% higher than its equity
STIM's debt to equity has soared by 172% YoY and by 23% QoQ
The company's debt has surged by 55% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.